Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study

Standardization and Cross Validation of Alloreactive IFNγ ELISPOT Assays Within the Clinical Trials in Organ Transplantation Consortium

(2013) I. Ashoor et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Multicenter Validation of Urinary CXCL9 as a Risk-Stratifying Biomarker for Kidney Transplant Injury

(2013) D. E. Hricik et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Prospective assessment of antidonor cellular alloreactivity is a tool for guidance of immunosuppression in kidney transplantation

(2013) Oriol Bestard et al.   KIDNEY INTERNATIONAL

Lymphodepletion and Homeostatic Proliferation: Implications for Transplantation

(2012) N. K. Tchao et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Immune Reconstitution Following Rabbit Antithymocyte Globulin

(2010) S. Gurkan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

New Equations to Estimate GFR in Children with CKD

(2009) G. J. Schwartz et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Pretransplant Donor-Specific and Non-Specific Immune Parameters Associated With Early Acute Rejection

(2009) Nancy L. Reinsmoen et al.   TRANSPLANTATION

Pretransplantation Cellular Alloreactivity Is Predictive of Acute Graft Rejection and 1-Year Graft Function in Kidney Transplant Recipients

(2009) K. Koscielska-Kasprzak et al.   TRANSPLANTATION PROCEEDINGS

Preferential Benefit of Antibody Induction Therapy in Kidney Recipients With High Pretransplant Frequencies of Donor-Reactive Interferon-γ Enzyme-Linked Immunosorbent Spots

(2008) Joshua J. Augustine et al.   TRANSPLANTATION